🇪🇺 Trobalt™ in European Union

EMA authorised Trobalt™ on 27 March 2011

Marketing authorisation

EMA — authorised 27 March 2011

  • Application: EMEA/H/C/001245
  • Marketing authorisation holder: Glaxo Group Limited
  • Local brand name: Trobalt
  • Indication: Trobalt is indicated as adjunctive treatment of drug-resistant partial-onset seizures with or without secondary generalisation in patients aged 18 years or older with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
  • Status: withdrawn

Read official source →

Frequently asked questions

Is Trobalt™ approved in European Union?

Yes. EMA authorised it on 27 March 2011.

Who is the marketing authorisation holder for Trobalt™ in European Union?

Glaxo Group Limited holds the EU marketing authorisation.